Garner Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 53)
Garner Health logo

Garner Health

ChallengerHealthcare

Employer Health Benefits & Care Navigation

Garner Health uses the largest US claims database (60B+ records) and 700-metric algorithms to steer employees to top-performing doctors, delivering avg. 12% employer cost savings and 80% lower employee out-of-pocket costs.

AI VisibilityBeta
Overall Score
C53
Category Rank
#239 of 596
AI Consensus
81%
Trend
stable
Per Platform
ChatGPT
50
Perplexity
48
Gemini
53

About

Garner Health is a care navigation company that uses advanced data analytics to connect employers and their employees with the highest-quality, most cost-effective physicians in their area. Founded in New York, Garner has assembled the largest medical claims database in the United States — containing over 60 billion records from 320 million patients — and built a proprietary algorithm that ranks physicians across 700 outcome and cost metrics. Employers integrate Garner into their health plan design, and employees receive financial incentives to choose Garner-recommended providers, typically paying 80% less out-of-pocket.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

53
Overall Score
90
#239
Category Rank
#2
81
AI Consensus
83
stable
Trend
stable
50
ChatGPT
92
48
Perplexity
93
53
Gemini
89
48
Claude
96
55
Grok
95

Key Details

Category
Employer Health Benefits & Care Navigation
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.